Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
News|Videos|July 1, 2024
A quick guide to the FreeStyle Libre 3 system
Advertisement
Advertisement
Related to this article
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
2
American Pharmacists Month: The Importance of Pharmacy-PBM Relationships
3
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
4
Pharmacists Step Up on Test-To-Treat This American Pharmacist Month
5